Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapy

Objectives: Second-line therapy for relapsed or refractory acute myeloid leukemia (R/R AML) involves either intensive chemotherapy (ICT) or azacitidine and venetoclax (AZAVEN), but their comparative infectious risks are not well established. Methods: This retrospective multicenter study evaluated in...

全面介绍

书目详细资料

Principais autores:	Maxime Bobo, Lucas Lefevre, Paul Mallet-Guy, Aurelia Chacon, Martin Eloit, Patrice Chevallier, Pierre Peterlin, Jean-Baptiste Mear, Tony Marchand, Maria-Pilar Gallego-Hernanz, Chama Mokeddem, Emmanuel Gyan, Aline Tanguy-Schmidt, Nicolas Vallet
格式:	Artigo
语言:	Inglês
出版:	Elsevier 2026-03-01
丛编:	International Journal of Infectious Diseases
主题:	AML Hypomethylating agent Venetoclax Intensive chemotherapy Infection Febrile neutropenia
在线阅读:	http://www.sciencedirect.com/science/article/pii/S1201971226000470
标签:	添加标签 没有标签, 成为第一个标记此记录!